TJO-087

· Taejoon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TJO-087, covering 2022-02-18 to 2022-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients [Phase 3]